FMC (FMC) said Monday it agreed to collaborate with Bayer to commercialize products containing Isoflex active in the EU and the UK.
Under the deal, both companies will bring the products to the winter cereal and oilseed rape markets.
Financial terms of the partnership were not disclosed.
Registration of Isoflex active in the EU is expected in 2025, pending regulatory approvals, according to FMC.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.